Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

by Ashley P. Taylor

A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.

by Cheryl Platzman Weinstock

Nutritional epidemiologist Carrie Daniel-MacDougall discusses research suggesting that what patients eat affects their gut microbes—and could influence cancer immunotherapy response.

by Anna Azvolinsky

A study suggests an association between hair dye use and breast cancer, and the U.S. Food and Drug Administration adds a new indication for an immunotherapy-chemotherapy combination.

by Kate Yandell